2,5-disubstituted morpholine orexin receptor antagonists
US8466281B2 · kind B2 · utility
21Cited by
4References
11Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Oct 15, 2009 |
| Grant date | Jun 18, 2013 |
| Priority date | — |
| Expiry date | Oct 15, 2029 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D413/14
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention is directed to 2,5-disubstituted morpholine amide compounds which are antagonists of orexin receptors, and which are useful in the treatment or prevention of neurological and psychiatric disorders and diseases in which orexin receptors are involved. The invention is also directed to pharmaceutical compositions comprising these compounds and the use of these compounds and compositions in the prevention or treatment of such diseases in which orexin receptors are involved.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.